Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sauerland

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2013
Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysisMatthias Stelljes, Utz Krug, Dietrich W Beelen, et al.
Leukemia|April 2, 2020
Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemiaTobias Herold, Maja Rothenberg-Thurley, Victoria V Grunwald, et al.
Annals of Hematology|May 6, 2004
Subgroup specific therapy effects in AML: AMLCG dataTh Büchner, W Hiddemann, W E Berdel, et al.
Annals of Hematology|July 12, 2011
Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML)Friederike Schneider, Eva Hoster, Stephanie Schneider, et al.
Leukemia|January 29, 2015
Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNetE Lengfelder, F Lo-Coco, L Ades, et al.
Blood|June 12, 2016
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemiaKlaus H Metzeler, Tobias Herold, Maja Rothenberg-Thurley, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2001
Remission induction therapy: the more intensive the better?T Büchner, W Hiddemann, W Berdel, et al.
Leukemia|March 12, 2016
Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemiaT Büchner, U O Krug, R Peter Gale, et al.
Leukemia|February 10, 2016
Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemiaU Krug, W E Berdel, R P Gale, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2013
Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysisMatthias Stelljes, Utz Krug, Dietrich W Beelen, et al.
Leukemia|April 2, 2020
Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemiaTobias Herold, Maja Rothenberg-Thurley, Victoria V Grunwald, et al.
Annals of Hematology|May 6, 2004
Subgroup specific therapy effects in AML: AMLCG dataTh Büchner, W Hiddemann, W E Berdel, et al.
Annals of Hematology|July 12, 2011
Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML)Friederike Schneider, Eva Hoster, Stephanie Schneider, et al.
Leukemia|January 29, 2015
Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNetE Lengfelder, F Lo-Coco, L Ades, et al.
Blood|June 12, 2016
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemiaKlaus H Metzeler, Tobias Herold, Maja Rothenberg-Thurley, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2001
Remission induction therapy: the more intensive the better?T Büchner, W Hiddemann, W Berdel, et al.
Leukemia|March 12, 2016
Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemiaT Büchner, U O Krug, R Peter Gale, et al.
Leukemia|February 10, 2016
Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemiaU Krug, W E Berdel, R P Gale, et al.
Pageof 7